Literature DB >> 23647436

Management of cytomegalovirus infection in haemopoietic stem cell transplantation.

Vincent Emery1, Mark Zuckerman, Graham Jackson, Celia Aitken, Husam Osman, Anthony Pagliuca, Mike Potter, Karl Peggs, Andrew Clark.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23647436     DOI： 10.1111/bjh.12363

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  19 in total

1.  Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.

Authors:  C Solano; E Giménez; J L Piñana; V Vinuesa; S Poujois; S Zaragoza; M Calabuig; D Navarro
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

2.  Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain.

Authors:  Carlos Solano; Rafael de la Cámara; Lourdes Vázquez; Javier López; Estela Giménez; David Navarro
Journal:  J Clin Microbiol       Date:  2015-06-10       Impact factor: 5.948

3.  When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?

Authors:  C Solano; E Giménez; J L Piñana; J C Hernández-Boluda; P Amat; V Vinuesa; D Navarro
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

4.  Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?

Authors:  Estela Giménez; Beatriz Muñoz-Cobo; Carlos Solano; Paula Amat; David Navarro
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

5.  A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients.

Authors:  Philip Roland Selby; Sepehr Shakib; Sandra L Peake; Morgyn S Warner; David Yeung; Uwe Hahn; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2021-01-30       Impact factor: 6.447

6.  Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.

Authors:  David Beauvais; Elodie Drumez; Didier Blaise; Régis Peffault de Latour; Edouard Forcade; Patrice Ceballos; Anne Uyttebroeck; Hélène Labussière; Stéphanie Nguyen; Jean-Henri Bourhis; Patrice Chevallier; Anne Thiebaut; Xavier Poiré; Sébastien Maury; Eric Deconinck; Thomas Cluzeau; Eolia Brissot; Anne Huynh; Marie-Thérèse Rubio; Alain Duhamel; Ibrahim Yakoub-Agha
Journal:  Bone Marrow Transplant       Date:  2020-12-18       Impact factor: 5.483

7.  Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients.

Authors:  Susanna K Tan; Jesse J Waggoner; Benjamin A Pinsky
Journal:  J Clin Virol       Date:  2015-06-10       Impact factor: 3.168

8.  Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients.

Authors:  Federica Forlanini; Jasmeen Dara; Christopher C Dvorak; Morton J Cowan; Jennifer M Puck; Morna J Dorsey
Journal:  Transpl Infect Dis       Date:  2020-11-29       Impact factor: 2.228

9.  [How I manage cytomegalovirus infection after hematopoietic stem cell transplantation].

Authors:  Q F Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-11-14

10.  Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy.

Authors:  Umberto Restelli; Davide Croce; Valeria Pacelli; Fabio Ciceri; Corrado Girmenia
Journal:  Infect Drug Resist       Date:  2019-05-08       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.